Organogenesis Holdings announced positive results from the PREPARE 1 trial, demonstrating that PuraPly AM combined with standard care significantly improves wound closure in hard-to-heal diabetic foot ulcers compared to standard care alone. Published in the Journal of Wound Care, these findings provide strong clinical evidence supporting PuraPly AM's effectiveness, which could influence future insurance coverage decisions. This success strengthens Organogenesis' position in the wound care market, especially as competitors retreat or exit. The company plans to leverage this data to expand adoption and reimbursement for PuraPly AM.
Organogenesis' clinical trial results for PuraPly AM provide context for health-related innovation. For readers following the health sector, here is Pluang's market snapshot as of Oct 13, 2026 03:02 WIB: Of 128 priced US health stocks, 66 rose and 61 fell. Notable movers include Sana Biotechnology Inc (SANA) at USD 2.62 with a 1-day change of -6.09%, Tilray Brands Inc (TLRY) at USD 3.35 down 5.23%, and Twist Bioscience Corp (TWST) at USD 151.54 down 5.16%.
Bureau Veritas disclosed its share buyback transactions conducted between October 5 and October 9, 2026. This activity reflects the company's ongoing efforts to manage its capital structure and potentially enhance shareholder value. Investors should ...
In Q3 2026, TRON DAO reported a milestone of $2.21 trillion in stablecoin settlements, with the network surpassing $30 trillion in cumulative transaction volume. The active user base grew by nearly 10%, and stablecoin supply increased to $93.88 billi...
Bureau Veritas disclosed its treasury shares transactions conducted between October 5 and October 9, 2026. This update is part of the company's regular reporting obligations to inform investors about changes in its treasury shares holdings. Such disc...
Pepeto, a new Ethereum-based cryptocurrency, has launched its page on CoinMarketCap, indicating a Binance listing is near. The project features a working bridge across Ethereum, BNB Chain, and Solana, with zero-cost token transfers and AI contract ch...
Crédit Agricole has signed an agreement to acquire 100% of IKB Deutsche Industriebank, a key financier for Germany's Mittelstand companies. This acquisition strengthens Crédit Agricole's expansion in Germany, Europe's largest economy, aligning with i...
